Abstract Purpose: To investigate the effect of aspirin on fractalkine (FKN) in rats with pulmonary embolism (PE and FKN. 
INTRODUCTION
Pulmonary embolism (PE) is a serious, lifethreatening disease, and is most commonly derived from deep vein thrombosis (DVT) of the lower extremities [1] . Several previous studies have demonstrated that cascade reactions of inflammation are associated with PE in the lung [2, 3] . FKN is one of the chemokines discovered in 1997, contains 373 amino acid residues and has adhesive and chemotactic activities. FKN, the only member of CX3C family, is widely distributed in lung, heart, brain, kidney, pancreas and skeletal muscles [4] and plays an important role in vascular inflammation and endothelial cell injury by binding to its specific receptor CX3CR1 [5] .
Our previous study found that TNF-α upregulates mRNA and protein expressions of FKN in human umbilical vein endothelial cells (HUVEC), and that curcuma had certain precautionary and therapeutic effects on PE rats [6, 7] . Recently, it was suggested that aspirin effectively reduces inflammation after PE [8] and prevents the recurrence of venous thromboembolism [9] . However, it is not clear whether aspirin diminishes PE by regulating the expressions of FKN. Therefore, the aim of this study was to evaluate the alteration of FKN in rats subjected to PE, and the effect of aspirin on FKN expression and lung morphological alterations in PE.
EXPERIMENTAL Animals
Male Sprague Dawley (SD) rats (262.63 ± 50.59 g) were purchased from Jiangnan Experimental Animal Center in Huishan, Wuxi, with the certificate no. SCXK (Su) 2009-0005. The experiments were reviewed and approved by the Animal Care and Use Committee of Zhejiang Chinese Medical University, China (no. 2012-0793). The animals were handled according to standard protocols for the use of laboratory animals [10] .
Reagents
Aspirin was purchased from Shijiazhuang Conic Pharmaceutical Co, Ltd (Shijiazhuang, China). Enzyme-linked immunosorbent assays (ELISA) kits for rat tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and FKN were purchased from Morrison Shanghai biotechnology Co, Ltd (Shanghai, China). TRizol Reagents and Platinum SYBR Green qPCR SuperMix UDG were purchased from Invitrogen Corporation (Camarillo, CA, USA). Reverse transcriptase kits (RevertAid First Strand cDNA synthesis Kit) were purchased from Fermentas Company, Canada. Recombinant DNase I (RNase-free) was purchased from Dalian TaKaRa Biotechnology Co, Ltd, China. Unless indicated otherwise, all other chemicals were of analytical purity. OD values were measured by the Molecular Devices Spectra max Plus 384. Quantitative polymerase chain reaction (qPCR) was run in a Bio-Rad MJ Mini Opticon Real-Time PCR system and analyzed by Bio-Rad CFX Manager.
Preparation of PE model
The rat PE model was established by injection of self-embolus into the right jugular vein. In essence, the rat blood was drawn from the orbital venous and placed in sterile bottles for 4 h to form a dense embolus, which was then trimmed into 2 mm 3 pieces and suspended in saline solution. After the rat was anesthetized with chloral hydrate (400 mg/kg, i.p.), the right jugular vein was isolated and 0.5 ml embolus suspension (approximately 15 -20 embolus) was quickly injected into the right jugular vein. The success of PE in the PE group was ascertained by respiratory manifestations (including accelerated and deepened breathing), and was confirmed by lung pathology. The histological feature of PE was alveolar hemorrhage and alveolar necrosis [11] .
Rat groups and treatment
Sixty-four SD male rats were divided into four groups (n = 16) according the random allocation table of SPSS software: control group (control), sham operation operation group, PE model group (PE) and PE + aspirin group (PE + aspirin). All rats were orally administered with aspirin (300 mg/kg) or the same volume of saline (1 ml/100 g) on day 1 and 40 min before PE surgery. The rats in control group were not injected with substance. The rats in Sham operation group received 0.5 ml normal saline injection into the right jugular vein instead of selfembolus. The rats in PE and PE + aspirin group received 0.5 ml self-embolus and also orally administered daily with aspirin (300 mg/kg) at the 6th hour following embolism. The rats in control, Sham operation and PE groups were orally administered with the same volume of saline daily. At 4th and 72nd hour following embolism, eight rats in each group were sacrificed under anesthesia and the blood and lung tissues harvested.
Measurement of serum cytokines
At 4th and 72nd hour following embolism, the rats were anesthetized with chloral hydrate (400 mg/kg), blood collected from the abdominal aorta, allowed to settle for 15 min, centrifuged (3000 rpm, 10 min, 4 °C), and the supernatant was used for FKN, IL-8, TNF-α, and IL-1β measurements with the double-antibody sandwich ABC-ELISA method.
Measurement of cytokine expression in lung tissues
At 4h and 72h following the embolism, rats were sacrificed under anesthesia and the lung tissues were harvested and stored at −70 °C. The frozen lung tissue was pulverized to a powder. Total RNA was extracted using Trizol. The mRNA expressions of FKN, TNF-α, and IL-1β in lung tissues were determined with qPCR. The RT reaction was amplified using TaqDNA polymerase and primers to murine FKN, TNF-α, and IL-1β cDNA as shown in Table 1 . 
Measurement of pathological changes in lung tissues
The rat lung was isolated and the wet weight index of lung was calculated using the following formula: the wet weight index of lung = lung weight / body weight × 100 % [12] . The lung tissue was fixed for 24 h in 10 % formalin solution, paraffin-embedded, and hematoxylineosinstaining (HE)-stained.
Statistical analysis
Values are expressed as mean ± standard deviation (SD). Statistical analysis was performed using one-way ANOVA to compare variables between groups, while linear regression was used to analyze the relevance between serum FKN and TNF-α, IL-8 as well as IL-1β following embolism. Statistical significant of differences was examined by paired-samples test in the corresponding group between 4 and 72 h following embolism. p < 0.05 was considered statistically significant. Statistical analysis was performed using SPSS software (version 17.0, SPSS Inc, USA).
RESULTS

Serum levels of FKN, IL-8, TNF-α and IL-1β
As shown in Fig 1, at 4 h following the embolism, the serum levels of FKN in PE group were significantly increased compared with that in the sham operation operation group (p < 0.05), and decreased after treatment with aspirin (p < 0.05) (Fig 1A) . The serum levels of IL-8 in PE group were higher than sham operation operation group (p < 0.05) (Fig 1B) , and reversed by treatment with aspirin at 4 h following the embolism. The serum levels of FKN, IL-8, TNF-α and IL-1β did not differ between control and sham operation group. TNF-α levels in PE group were significantly decreased relative to the aspirin treatment group (p < 0.05) (Fig 1C) . There were no significant differences of the serum IL-1β in all groups (Fig 1 D) . At 72 h following the embolism, the serum FKN, IL-8, TNF-α and IL-1β were all markedly increased in the PE group compared with that in the sham operation group (p < 0.05), and decreased after treatment with aspirin (p < 0.05). The serum cytokines measured did not differ between control and sham operation operation. Compared with the corresponding group at 4 h following the embolism, FKN levels in PE group and PE + aspirin group at 72 h were significantly increased (p < 0.01); TNF-α in the PE group were higher at 72 h following (p < 0.01), but in PE + aspirin group they were decreased significantly (p < 0.01). The IL-1β in the PE group at 72 h following the embolism was significantly increased (p < 0.05) (Fig 1) .
Linear regression
Through the analysis of the correlation between the serum FKN and TNF-α, IL-8 as well as the IL-1β following the embolism, we found that the serum FKN had nothing to do with IL-1β，but was only related to IL-8 and TNF-α. This is evident from Eqs 1 and 2. By analysis of the correlation between serum FKN, and TNF-α, IL-8 and IL-1β following the embolism, it was observed that serum FKN had no link with IL-1β, but was only related to IL-8 and TNF-α. significantly increased (p < 0.01) in the PE group compared with that in the sham operation group (Fig 3) , but decreased after treatment with aspirin (p < 0.01). All the mRNA expression of cytokines measured did not differ between control and sham operation operation. The mRNA expression of FKN and TNF-α in PE group at 72h following the embolism were significantly higher than the corresponding group at 4h (p < 0.05), and there were no difference in the other groups (Fig 3) .
Wet weight index of lung and rat lung pathology
As shown in Fig 4, at 72 h following the embolism, the wet weight index of lung was markedly increased in the PE group compared with that in the control group (p < 0.05), but decreased significantly after treatment with aspirin (p < 0.01). There were no significant differences of the wet weight index of lung between the control, sham operation, PE group at 4 h following the embolism, but increased after treatment with aspirin (p < 0.05). Similarly, the wet weight index of lung did not differ between control and sham operation. At 72 h following the embolism, the wet weight index of lung was markedly lower than in the corresponding group at 4 h after treatment with aspirin (p < 0.01). Lung pathological examination was done in a total of 64 rats in 4 groups on two time points: at 4 h and 72 h (32 rats each) following embolism. At 4 h following embolism, the alveolar wall vessels was dilated and congested, with accompanying mild edema and inflammatory cell infiltration in PE group, while aspirin treatment attenuated these pathological changes induced by PE (Fig 5a, b, c and d) . At 72 h following embolism, the alveolar wall vessels were markedly expanded and congested, but this was obviously reduced by aspirin (Fig 5e, f and h ).
DISCUSSION
Pulmonary embolism is the third most common cause of death from cardiovascular disease after heart attack and stroke. Venous thromboembolism and atherothrombosis share common risk factors and the common pathophysiological characteristics of inflammation, hypercoagulability, and endothelial injury [3] . Previous studies suggest that the adhesion between endothelial cells, platelet and leukocyte is involved in PE, and the inflammatory response induced by PE further injuries the lung [13] . FKN together with its receptor on the endothelial cells is potent enough to capture the white blood cells to adhere closely to vascular endothelium even in the high blood flow [14] . When the aorta is full of inflammatory cells gathered by FKN, it will play a role in the pathogenesis of some diseases, such as acute lung injury, pulmonary hypertension [15] , and ischemic stroke [16] . . At 72 h following the embolism, the alveolar wall vessels was markedly expanded and congested, but these were reduced by aspirin However, to the best of our knowledge, there are no reports on the relationship between FKN and PE.
Our previous experiments have found that at the two time points (4 and 72 h) following embolism, reflected PE characteristics [7] . In order to reduce the number of mice used we did not go beyond these time points. In this study, the lung pathological examination of the rats at 4 h following embolism showed that aspirin attenuated the pathological injuries of the lung induced by PE. At 72 h following embolism, the extent of lung congestion was markedly reduced by aspirin application, and the number of rats with infarction also decreased from 25 to 12.5 %. These results suggest that prophylactic use of aspirin might reduce the mortality induced by PE in rats by attenuating lung pathological damage. There was no difference between control and sham operation groups at 4 h and 72 h following embolism, indicating that sham operation had no effect on the lung morphology.
These results suggest that aspirin is effective in decreasing PE-induced FKN. At 72 h following embolism, serum FKN, IL-8, TNF-α and IL-1β in the PE group all significantly increased but aspirin attenuated these increases, indicating that these four cytokines might be closely related to advanced PE, and aspirin may diminish advanced PE-induced lung injuries by decreasing serum FKN, IL-8, TNF-α and IL-1β. This study also found that at 4 and 72 h following embolism, mRNA expressions of FKN, TNF-α and IL-1β in lung tissues significantly increased. The increases were reversed by aspirin, suggesting that aspirin can inhibit lung inflammation. These results agree with the report that aspirin can inhibit the proinflammatory cytokines (TNF-α, IL-1β, IL-8) of lung [17] . Our previous study found that TNF-α level of 0.5 ng/ml significantly stimulates expression of FKN mRNA and also protein expression in HUVECs using Western-blot technique [6] . Harrison et al [18] also reported that IL-1 or TNF-α stimulated FKN expression in endothelial cells. In addition, type I IFN induces CX3CL1 secretion from human pulmonary arterial-endothelial cells (HPAEC) but this can be prevented by Janus protein tyrosine kinase (JAK) inhibitor [19] . Based on linear regression data, serum FKN has no correlation with IL-1β after embolism, but has a moderate correlation with IL-8 and TNF-α. This suggests that serum IL-8 and TNF-α stimulates the secretion of FKN after embolism, and that the inhibition of serum FKN by aspirin is linked to the reduction in IL-8 and TNF-α.
CONCLUSION
This study indicates that aspirin has protective effects against PE-induced lung injuries. Furthermore, the mechanisms of the protective effects of aspirin might be mediated by suppression of the expressions of IL-8, TNF-α, IL-1β and fractalkine.
